The kinetic activity of KPC-3, a plasmid-encoded class A carbapenemase, was studied. It hydrolyzed penicillins, cephalosporins, carbapenems, and even sulbactam. The best substrate was cephalothin (k cat/K m ‫؍‬ 3.48 M ؊1 s ؊1 ). The efficiency of the enzyme was similar for imipenem and meropenem (k cat /K m , 1.4 and 1.94 M ؊1 s ؊1 , respectively).
In this study we purified KPC-3 and subjected the enzyme to kinetic characterization.
An isolate of E. coli (isolate 233) showing reduced susceptibility to carbapenems was referred to Creighton University from Hackensack University Medical Center. It was subsequently found to produce KPC-3 (report in press).
The isolate was grown in 4 liters of Luria-Bertani broth at 37°C (250 rpm) for 8 h, harvested, and suspended in 30 mM Tris-HCl buffer (pH 8.0) containing 30% sucrose. The periplasmic content was extracted as described previously (12) . Purification was achieved using a HiPrep 16/10 SP XL column (Amersham Biosciences AB, Uppsala, Sweden) equilibrated in 10 mM acetate buffer (pH 5.0). Fractions displaying ␤-lactamase activity, observed as the initial rate of hydrolysis of nitrocefin (100 M) (⌬ε 482 ϭ ϩ10,000 M Ϫ1 cm Ϫ1 ) (Oxoid Ltd., Hampshire, United Kingdom) were obtained after elution with a linear gradient of NaCl (0 to 400 mM). After concentration using Amicon ultrafiltration membranes (Millipore Corporation, Bedford, MA) and overnight dialysis in 10 mM morpholineethanesulfonic acid (MES) buffer (pH 5.5) at 4°C, the sample was reloaded onto a Mono S HR 5/5 column (Amersham Pharmacia Biotech, Uppsala, Sweden), equilibrated in MES buffer (pH 5.5), and eluted with a linear gradient of NaCl (0 to 300 mM). The entire purification process was done with an AKTA purifier (Amersham Pharmacia Biotech). The purity of the ␤-lactamase preparation was controlled using 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and staining with Coomassie brilliant blue. The purity achieved was above 90%. The purified enzyme was then dialyzed overnight at 4°C in phosphate buffer (pH 7.0) and concentrated. Four liters of culture yielded a total of 0.27 mg of pure enzyme. After determination of the protein concentration using a BioRad (Richmond, Calif.) protein assay, 20 g/ml bovine serum albumin was added. The N-terminal sequence was determined using a Procise 492clC-1 protein sequencer (Applied Biosystems, Foster City, Calif.), and the kinetic parameters were determined with the pure enzyme.
All kinetics studies were done by measuring hydrolysis rates with a Shimadzu (Kyoto, Japan) UV-2550 spectrophotometer connected to a personal computer. To determine the kinetic parameters, 6 to 10 different concentrations of each ␤-lactam were used. Each reported parameter is an average of three separate measurements. All kinetic parameters were acquired by measuring the initial hydrolysis rate of the ␤-lactam under study at a constant temperature of 30°C, using 50 mM phosphate buffer (pH 7.0). Analysis of the data was done using the Hanes-Woolf linearization of the Michaelis-Menten equation. For all poor substrates, the competitive inhibition constant (K i ) was determined by competition experiments between the tested ␤-lactam and 100 M nitrocefin. Hydrolysis of the substrate at a concentration 10 times the K m (K i ) value or higher yielded the catalytic constants (k cat ) for poor substrates. The k cat value for cefoxitin was obtained using 100 M substrate with 1.1 ϫ 10 Ϫ7 M enzyme. The N-terminal sequence of KPC-3 was determined as LT NLVAEPFAKLE. Table 1 , respectively), which were similar overall to those exhibited for ampicillin and cephaloridine. The substrate profiles for the three enzymes were similar overall, although the catalytic efficiency of KPC-3 appeared to be somewhat higher with some substrates, including oxyiminocephalosporins and carbapenems. One of the notable differences is the behavior of this enzyme with ceftazidime. The catalytic activity (k cat ) with ceftazidime (3.0 s Ϫ1 Ϯ 0.01) was approximately 30 times higher than those of KPC-1 and KPC-2 (0.1 s Ϫ1 for both). Due to this, KPC-3 was 30 times more efficient than KPC-1 toward this substrate. Moreover, KPC-3 showed a lower affinity for cefoxitin than the other enzymes. The present findings, therefore, suggest that the amino acid substitution that differentiates KPC-3 from KPC-2 (H272Y) could have a functional significance. A molecular modeling analysis based on the structure of the TOHO-1 enzyme (25), now called CTX-M-44, suggested that the H272Y mutation (which would be at a position similar to that of R274 in TOHO-1) could influence the positions of R209, which interacts with the substrate carboxylate. Further investigation will be necessary to clarify these matters.
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